Liping P. Su
Taiyuan, 030013, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 149 publications
Correction to: Prognostic factors and nomogram development for adult diffuse large B-cell lymphoma: a single-center retrospective cohort study.
Journal: BMC cancer
Published: August 23, 2026
Anti-TIM-3 antibody TQB2618 in combination with penpulimab in relapsed or refractory classic Hodgkin lymphoma previously treated with PD-1/PD-L1 therapy: a multicenter, open-label, single-arm, phase Ib clinical trial.
Journal: Journal for immunotherapy of cancer
Published: March 30, 2026
Combined oral PI3Kδ inhibitor linperlisib and HDAC inhibitor chidamide in relapsed/refractory peripheral T-cell lymphoma: a multicenter phase 1 trial.
Journal: Leukemia & lymphoma
Published: March 03, 2026
Upfront Autologous Stem Cell Transplantation in First Complete Remission for Advanced-Stage Extra-Nodal NK/T-Cell Lymphoma: A Multicenter Retrospective Study.
Journal: American journal of hematology
Published: February 19, 2026
Development and Validation of a Novel Geriatric Risk Score for Prognostication in Older Patients With Hodgkin Lymphoma: A Multicenter Retrospective Study.
Journal: American journal of hematology
Published: February 06, 2026
Efficacy, toxicity, and prognostic factors of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in elderly patients with diffuse large B-cell lymphoma: a single-center retrospective cohort study.
Journal: Frontiers in oncology
Published: January 16, 2026
Long-term outcomes of vindesine or vincristine substitutions for vinblastine in classical Hodgkin lymphoma.
Journal: Chinese medical journal
Published: January 12, 2026
Multiple myeloma burden and risk factors in China vs. high-income Asia Pacific: a macro-micro analysis.
Journal: Frontiers in public health
Published: January 10, 2026
Nutritional vulnerability, food insecurity, and unmet supportive care needs in multiple myeloma: a cross-sectional study from China.
Journal: Frontiers in nutrition
Published: December 22, 2025
Prognostic factors and nomogram development for adult diffuse large B-cell lymphoma: a single-center retrospective cohort study.
Journal: BMC cancer
Published: December 21, 2025
Regulation of tumor metastasis and lipid metabolism reprogramming via the CCL5/GGT5 axis in gastric cancer.
Journal: International journal of biological macromolecules
Published: October 02, 2025
Glofitamab vs. real-world regimens in Chinese patients with third- or later-line relapsed/refractory diffuse large B-cell lymphoma: an external control study.
Journal: Cancer biology & medicine
Published: September 30, 2025
Last Updated: 09/26/2026